Global Herpes Simplex Virus (HSV) Vaccines Market Growth 2025-2031

December 2025 | 83 pages | ID: G6797184355FEN
LP Information

Abstracts

The global Herpes Simplex Virus (HSV) Vaccines market size is predicted to grow from US$ 979 million in 2025 to US$ 1433 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Herpes Simplex Virus (HSV) Vaccines Industry Forecast” looks at past sales and reviews total world Herpes Simplex Virus (HSV) Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Herpes Simplex Virus (HSV) Vaccines sales for 2025 through 2031. With Herpes Simplex Virus (HSV) Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herpes Simplex Virus (HSV) Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Herpes Simplex Virus (HSV) Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Herpes Simplex Virus (HSV) Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herpes Simplex Virus (HSV) Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herpes Simplex Virus (HSV) Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herpes Simplex Virus (HSV) Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus (HSV) Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• GEN-003
• VCL-HB01
• HSV529
• Others

Segmentation by Application:

• HSV-1 (Oral Herpes)
• HSV-2 (Genital Herpes)

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi
• GlaxoSmithKline
• Genocea Biosciences
• Vical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Herpes Simplex Virus (HSV) Vaccines market?

What factors are driving Herpes Simplex Virus (HSV) Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Herpes Simplex Virus (HSV) Vaccines market opportunities vary by end market size?

How does Herpes Simplex Virus (HSV) Vaccines break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Herpes Simplex Virus (HSV) Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Herpes Simplex Virus (HSV) Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type
  2.2.1 GEN-003
  2.2.2 VCL-HB01
  2.2.3 HSV529
  2.2.4 Others
2.3 Herpes Simplex Virus (HSV) Vaccines Sales by Type
  2.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Type (2020-2025)
2.4 Herpes Simplex Virus (HSV) Vaccines Segment by Application
  2.4.1 HSV-1 (Oral Herpes)
  2.4.2 HSV-2 (Genital Herpes)
2.5 Herpes Simplex Virus (HSV) Vaccines Sales by Application
  2.5.1 Global Herpes Simplex Virus (HSV) Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Herpes Simplex Virus (HSV) Vaccines Breakdown Data by Company
  3.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Company
3.4 Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Location Distribution
  3.4.2 Players Herpes Simplex Virus (HSV) Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HERPES SIMPLEX VIRUS (HSV) VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Herpes Simplex Virus (HSV) Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Herpes Simplex Virus (HSV) Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Herpes Simplex Virus (HSV) Vaccines Sales Growth
4.4 APAC Herpes Simplex Virus (HSV) Vaccines Sales Growth
4.5 Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth
4.6 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth

5 AMERICAS

5.1 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country
  5.1.1 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025)
5.2 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025)
5.3 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region
  6.1.1 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2020-2025)
6.2 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025)
6.3 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Herpes Simplex Virus (HSV) Vaccines by Country
  7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025)
7.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025)
7.3 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines by Country
  8.1.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines
10.3 Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
10.4 Industry Chain Structure of Herpes Simplex Virus (HSV) Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Herpes Simplex Virus (HSV) Vaccines Distributors
11.3 Herpes Simplex Virus (HSV) Vaccines Customer

12 WORLD FORECAST REVIEW FOR HERPES SIMPLEX VIRUS (HSV) VACCINES BY GEOGRAPHIC REGION

12.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region
  12.1.1 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Type (2026-2031)
12.7 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
  13.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
13.3 Genocea Biosciences
  13.3.1 Genocea Biosciences Company Information
  13.3.2 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
  13.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Genocea Biosciences Main Business Overview
  13.3.5 Genocea Biosciences Latest Developments
13.4 Vical
  13.4.1 Vical Company Information
  13.4.2 Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
  13.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Vical Main Business Overview
  13.4.5 Vical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Herpes Simplex Virus (HSV) Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Herpes Simplex Virus (HSV) Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of GEN-003
Table 4. Major Players of VCL-HB01
Table 5. Major Players of HSV529
Table 6. Major Players of Others
Table 7. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025) & (K Units)
Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
Table 9. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2020-2025) & ($ million)
Table 10. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2020-2025)
Table 11. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Herpes Simplex Virus (HSV) Vaccines Sale by Application (2020-2025) & (K Units)
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Sale Market Share by Application (2020-2025)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2020-2025) & ($ million)
Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2020-2025)
Table 16. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Herpes Simplex Virus (HSV) Vaccines Sales by Company (2020-2025) & (K Units)
Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2020-2025)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2020-2025)
Table 21. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Producing Area Distribution and Sales Area
Table 23. Players Herpes Simplex Virus (HSV) Vaccines Products Offered
Table 24. Herpes Simplex Virus (HSV) Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Geographic Region (2020-2025)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country/Region (2020-2025)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
Table 36. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2020-2025)
Table 37. Americas Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025) & (K Units)
Table 39. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025) & (K Units)
Table 40. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2020-2025)
Table 42. APAC Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025) & (K Units)
Table 44. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025) & (K Units)
Table 45. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025) & (K Units)
Table 48. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus (HSV) Vaccines
Table 54. Key Market Challenges & Risks of Herpes Simplex Virus (HSV) Vaccines
Table 55. Key Industry Trends of Herpes Simplex Virus (HSV) Vaccines
Table 56. Herpes Simplex Virus (HSV) Vaccines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 59. Herpes Simplex Virus (HSV) Vaccines Customer List
Table 60. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Herpes Simplex Virus (HSV) Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Herpes Simplex Virus (HSV) Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Sanofi Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 75. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
Table 76. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Sanofi Main Business
Table 78. Sanofi Latest Developments
Table 79. GlaxoSmithKline Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
Table 81. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Latest Developments
Table 84. Genocea Biosciences Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
Table 86. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Genocea Biosciences Main Business
Table 88. Genocea Biosciences Latest Developments
Table 89. Vical Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolios and Specifications
Table 91. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Vical Main Business
Table 93. Vical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Herpes Simplex Virus (HSV) Vaccines
Figure 2. Herpes Simplex Virus (HSV) Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Herpes Simplex Virus (HSV) Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of GEN-003
Figure 12. Product Picture of VCL-HB01
Figure 13. Product Picture of HSV529
Figure 14. Product Picture of Others
Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2025
Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2020-2025)
Figure 17. Herpes Simplex Virus (HSV) Vaccines Consumed in HSV-1 (Oral Herpes)
Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Market: HSV-1 (Oral Herpes) (2020-2025) & (K Units)
Figure 19. Herpes Simplex Virus (HSV) Vaccines Consumed in HSV-2 (Genital Herpes)
Figure 20. Global Herpes Simplex Virus (HSV) Vaccines Market: HSV-2 (Genital Herpes) (2020-2025) & (K Units)
Figure 21. Global Herpes Simplex Virus (HSV) Vaccines Sale Market Share by Application (2024)
Figure 22. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application in 2025
Figure 23. Herpes Simplex Virus (HSV) Vaccines Sales by Company in 2025 (K Units)
Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company in 2025
Figure 25. Herpes Simplex Virus (HSV) Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Herpes Simplex Virus (HSV) Vaccines Sales 2020-2025 (K Units)
Figure 30. Americas Herpes Simplex Virus (HSV) Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Herpes Simplex Virus (HSV) Vaccines Sales 2020-2025 (K Units)
Figure 32. APAC Herpes Simplex Virus (HSV) Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Herpes Simplex Virus (HSV) Vaccines Sales 2020-2025 (K Units)
Figure 34. Europe Herpes Simplex Virus (HSV) Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
Figure 40. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
Figure 48. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. France Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
Figure 75. Industry Chain Structure of Herpes Simplex Virus (HSV) Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Forecast by Region (2026-2031)
Figure 78. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Application (2026-2031)